The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD ...
Lung Disease Therapeutics Market. The global lung disease therapeutics market is on an impressive growth trajectory, ...
Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms.
Approximately 1 in 20 individuals diagnosed with RSV in outpatient settings were hospitalised within 28 days. Read more.
The clinical trial, led by scientists from King’s College London and sponsored by the University of Oxford, with support from drug firm AstraZeneca UK, was conducted at Oxford University Hospitals NHS ...
The global capnography equipment market is projected to grow from USD 334 million in 2021 to USD 536.35 million by 2032, at a ...
On December 2, 2024, Apogee Therapeutics, a clinical-stage biotechnology company, released a press release detailing the significant advancements made in its novel biologic programs for Inflammatory ...
NCR, there has been a huge surge in the demand for respiratory drugs like Foracort, which has emerged as the top-selling ...
Farmers face higher COPD risks due to exposure on farms. Act fast on symptoms like breathlessness to protect lung health and avoid severe outcomes.
The Environmental Protection Agency’s attempts to reckon with formaldehyde have been repeatedly thwarted by the companies ...
Glenmede Trust Co. NA lowered its stake in Verona Pharma plc (NASDAQ:VRNA – Free Report) by 13.1% during the 3rd quarter, ...
Health and Me on MSN5h
Can Vitamin D Cure COVID-19?The sunshine vitamin’s role in immune health and respiratory protection, including its potential to mitigate severe COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback